ABSTRACT NUMBER: ESOC2026A1606 VON WILLEBRAND FACTOR AS A PROGNOSTIC BIOMARKER IN ISCHEMIC STROKE

Mehdi Khobzi, Jean Philippe Desilles · 2026

Read ABSTRACT NUMBER: ESOC2026A1606 VON WILLEBRAND FACTOR AS A PROGNOSTIC BIOMARKER IN ISCHEMIC STROKE by Mehdi Khobzi, Jean Philippe Desilles (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13144880.txt.

Description

Mehdi Khobzi and Jean Philippe Desilles test in 2026 whether levels of a clotting protein in blood can forecast recovery after a severe ischemic stroke. The protein drives clot and inflammation interplay and has been tied to resistance against clot busting care. Records covered 295 patients with a blocked large vessel in the front of the brain, all treated with a catheter procedure, some with a clot drug as well. Blood was drawn at the start of the procedure.

Higher protein levels tied on their own to lower odds of a good outcome at ninety days in patients whose vessel had not already opened from the drug. That link faded in the subgroup that got the drug. Links to scan signs of damage and bleeding were also probed.

Catalog record

CREATORMehdi Khobzi, Jean Philippe Desilles
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13144880

Browse the full library · About the Tower of Babel